Press Releases
-
Applications of Liposomal Drug Delivery System Technology
-
As Paradigm Clinical Research Expands, So Does the Executive Team
Paradigm Clinical Research (Paradigm), with three dedicated research sites in California and Colorado, announced it has grown its executive leadership team, bringing on board Travis Milnes as chief financial officer (CFO) and Amy Henderson as head of clinical operations.
Oct 5, 2022
-
Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration with Tasso
Q2 Solutions, a wholly owned subsidiary of IQVIA and a leading global clinical trial laboratory services organization, today announced the launch of the first self-collection safety lab panel for U.S. clinical trial participants by a leading global clinical trial laboratory.
Oct 5, 2022
-
Genezen delivers next phase of cGMP lentiviral and retroviral vector production facility expansion
Genezen has completed another expansion phase at its viral vector process development and cGMP vector production facility in Fishers, Indiana (US).
Oct 6, 2022
-
Paradigm Clinical Research Names Industry Veteran Kurt Mussina as CEO as Expansion Plans Are Set in Motion
Paradigm Clinical Research names clinical research industry leader Kurt Mussina as CEO.
Sep 26, 2022
-
Quotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics® Programs
Company increases laboratory and clinical capacity to meet demand for fully integrated drug development capabilities
Oct 4, 2022
-
LILLY RECEIVES MHRA MARKETING AUTHORISATION FOR BARICITINIB (OLUMIANT®) FOR THE TREATMENT OF SEVERE ALOPECIA AREATA (AA) IN ADULT PATIENTS
-
Biotium’s New Laser Diode Gel Illuminator Offers a Superior Alternative to LED and UV-based Illumination
Biotium has announced the release of the next-generation Gel-Bright™ Laser Diode Gel Illuminator, offering a better alternative to UV and LED-based gel imaging.
Oct 3, 2022
-
dMed | Clinipace announce corporate name change to Caidya
dMed |Clinipace, the established clinical research organization serving global innovators, such as biotechs, announced today that it is changing its corporate name to Caidya
Oct 2, 2022
-
BioIVT Announces Global eCommerce Collaboration With Charles River Laboratories Avian Vaccine Services
Charles River Avian products, which are used for virus research and to produce veterinary and human vaccines, are now available through the BioIVT Digital Portal.
Oct 2, 2022
-
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022
-
Biopharma PEG Offers GMP & Non-GMP Grade PEG Derivatives Manufacture Services
-
Huateng Pharma Develops Sitagliptin & Linagliptin Anti-diabetic Intermediates
-
Emmes Acquires Clinical Edge
In latest news story from Emmes (CRO) announcing the acquisition of Clinical Edge, which trains and certifies visual function examiners at investigator sites conducting Phase I to IV ophthalmic clinical trials. OptymEdge - The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services.
Sep 27, 2022
-
Monon Bioventures receives nearly $400,00 funding to develop Purdue-discovered glioblostoma treatment
Monon Bioventures receives funding to develop glioblostoma treatment
Sep 27, 2022
-
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts
-
Quanticate partners with Cancer Research UK to launch DETERMINE Study
-
Heart pacing company Ceryx Medical partners with Osypka Medical
Ceryx Medical Limited has announced a partnership with Berlin-based Osypka Medical to develop a heart pacing device that will change the way patients with heart failure and other cardiac conditions are treated.
Sep 26, 2022
-
Creative Biostructure Uncovers Insights for Pathology Research with Advanced iEM Platform
-
Lifeasible Released Rare Plant Tissue Culture Service to for Research Use